Observational study / 2005
Irritable bowel syndrome was estimated at 14.1% prevalence in a US survey and was linked to more days off work and days in bed.
A two-phase community survey using quota sampling and random-digit telephone dialing screened 5,009 US individuals to assess irritable bowel syndrome (IBS) prevalence and impact. Total IBS prevalence was 14.1% (3.3% medically diagnosed and 10.8% undiagnosed but meeting diagnostic criteria). Alternating constipation and diarrhoea was reported by 74% of medically diagnosed and 63% of undiagnosed sufferers. IBS sufferers reported more days off work (6.4 vs. 3.0 days), more days in bed, and greater reductions in daily activities compared to non-sufferers.
Shows an association, not proof of cause and effect.
- Study type
- Two-phase community survey
- Who was studied
- 5,009 individuals in the United States undergoing telephone screening interviews
- What was measured
- Prevalence, symptom patterns, lifestyle, and impact on well-being and daily activities
THE PAPER
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Aliment Pharmacol Ther, 2005.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.